4-(cyclohexylamino)-3-[(phenylmethyl)amino]-N-[2-(1-piperazinyl)ethyl]-benzenesulfonamide, monohydrochloride, 50mg

1-Methylcyclopropaneacetic acid, 97%, 500mg

Methyl 4-bromo-5-methylpyrazolo[1,5-a]pyridine-3-carboxylate, 98%, 250mg

3-(methoxycarbonyl)cyclohexane-1-carboxylic acid, 95.0%, 10g

3,5-Dimethyl-2-pyrrolecarboxaldehyde>98.0%(GC)1g

(4-Methylbenzyl)hydrazine dihydrochloride, 95%, 1g

1-Phenyl-1,3-diazinane-2,4-dione, 97%, 5g

Glass syringe with Luer connection (glass), 1 ml, 1 piece

1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride, 98%, 250mg

3-chloro-4-fluoro-4'-(3-pyrrolinomethyl) benzophenone, 97.0%, 1g

1-Iodo-2-methoxyethane, 95.0%, 250mg

(S)-2-((tert-butoxycarbonyl)amino)-3-(5-chloro-1H-indol-3-yl)propanoic acid, 97%, 250mg

1-Methyl-1,2,3,4-tetrahydro-pyrrolo[1,2-a]pyrazine, 95.0%, 1g